1. Home
  2. |Insights
  3. |Contractors and Competition - Antitrust Probes of Classified Intel Require a Delicate Balance

Contractors and Competition - Antitrust Probes of Classified Intel Require a Delicate Balance

Client Alert | less than 1 min read | 08.26.25

In our latest Bloomberg Law article about the growing range of antitrust concerns facing government contractors, Crowell lawyers Michelle D. Coleman and Lauren Fleming explore best practices for contractors who are navigating antitrust investigations involving classified information. 

They explore the delicate balance for contractors who must protect sensitive information and handle company employees who might become witnesses with care, while maintaining strong relationships with intelligence agency customers.

Click here to read more about contractors and competition. 

Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...